Ozone, Chime’s health marketing agency, has been appointed to handle the campaign, launched last week to coincide with the publication of a clinical trial among post-menopausal women that positively assessed the effects of vibration training in the treatment of osteoporosis.
VibroGym MD Kevin Barclay-Webb said the product was ‘well established among sports and fitness professionals’ but the PR drive would attempt to boost sales as a ‘therapeutic application’.
Barclay-Webb said Ozone would target healthcare professionals, in addition to specialist medical media.
The £100,000 campaign will also include ‘advocacy’ and educational work with patient groups, as well as website development.
VibroGym helps speed recovery from sports injuries, but Barclay-Webb said: ‘Our research is showing remarkable results in treating ailments such as arthritis and a range of conditions causing restricted mobility.’
Chelsea-based Ozone was formerly known as Harvard Health and relaunched in December. Chairman Gareth Zundel leads the VibroGym account.
Ozone was hired last month to promote Johnson & Johnson MSD’s cholesterol-lowering drug Zocor (PRWeek, 20 February).